BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹4,102 Cr | ₹3,985 Cr | ₹2,588 Cr | ₹3,420 Cr | ₹2,254 Cr |
What is the latest Capital Work in Progress ratio of BIOCON ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹4,102 Cr |
| Mar2024 | ₹3,985 Cr |
| Mar2023 | ₹2,588 Cr |
| Mar2022 | ₹3,420 Cr |
| Mar2021 | ₹2,254 Cr |
How is Capital Work in Progress of BIOCON Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,102 Cr | 2.92 | |
| Mar2024 | ₹3,985 Cr | 54.02 | |
| Mar2023 | ₹2,588 Cr | -24.35 | |
| Mar2022 | ₹3,420 Cr | 51.78 | |
| Mar2021 | ₹2,254 Cr | - | |
Compare Capital Work in Progress of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹52,998.7 Cr | -5.9% | 8.4% | 21.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -5.9% |
8.4% |
21.5% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses